Immix Biopharma Inc (IMMX) Live Share Price, Invest From India

Immix Biopharma Inc Stock Performance

as on October 31, 2025 at 1:29 am IST

Day's Low
Day's High
$3.6
Day's Price Range
$3.85
$3.67
1.91%
Downside
4.90%
Upside
52 Week's Low
52 Week's High
$1.34
52-Week Price Range
$4
$3.67
63.49%
Downside
8.99%
Upside

Immix Biopharma Inc share price movements today

Previous Close: $3.72
Open: $3.75
Volume: 796.8K
Day's Low - High: $3.6 - $3.85
52 Week Low - High: $1.34 - $4

Immix Biopharma Inc Historical Returns

1 Month Return: + 76.44 %
3 Month Return: + 34.93 %
1 Year Return: + 129.37 %
3 Year Return: + 267 %
5 Year Return: 0 %

Immix Biopharma Inc Stock Fundamentals & Key Indicators

Check Immix Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$122.9M

EPS (TTM)

-0.675

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-23.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-162.04%

Immix Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immix Biopharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Immix Biopharma Inc	BUY	$122.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$63.1B	265.59%	-505.15	-12.96%
Beone Medicines Ltd	NA	$36.1B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$107.0B	101.52%	29.67	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$68.6B	20.33%	15.65	32.13%

Stock Returns calculator for Immix Biopharma Inc Stock including INR - Dollar returns

The Immix Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Immix Biopharma Inc investment value today

Current value as on today

₹2,35,042

Returns

₹1,35,042

(+135.04%)

Returns from Immix Biopharma Inc Stock

₹1,29,375 (+129.37%)

Dollar Returns*

₹5,667 (+5.67%)

Analyst Recommendation on Immix Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Immix Biopharma Inc. Average target price of $8

Immix Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Immix Biopharma Inc.

What analysts predicted

54.13%UPSIDE

Target Price

Current Price

$3.67

Analyzed by

7 Analysts

Target

$8.00

Immix Biopharma Inc target price $8, a slight upside of 54.13% compared to current price of $3.67. According to 7 analysts rating.

Immix Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for Immix Biopharma Inc Stock has increased by 90% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 1, 2025 to October 31, 2025

Change:90% versus previous 30 day period

Immix Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-2	-3	-4	-5	-5	-4	-7	-4	-4	-6
EBITDA	-2	-3	-4	-5	-5	-4	-7	-4	-4	-6
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-3	-4	-5	-5	-4	-7	-4	-4	-6
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-2	-3	-4	-5	-5	-4	-7	-4	-4	-6
Net Profit Margin	0.00%	0.00%	0.00%	-106385.95%	0.00%	0.00%	0.00%	-4997.46%	0.00%	0.00%

Immix Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-89	-	-
Gross Profit	0	0	0	-89	0	0
Operating Income	0	0	-1	-8	-16	-22
EBITDA	0	0	-1	-8	-16	-21
Interest Expense	0	0	0	0	-	-
Depreciation	0	0	0	0	0	0
Income Before Tax	0	-1	-24	-8	-15	-21
Income Tax Expense	0	0	0	0	0	0
Net Income	0	-1	-24	-8	-15	-21
Net Profit Margin	0.00%	0.00%	0.00%	9.19%	0.00%	0.00%

Immix Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-4	-5	-5	-4	-7	-4	-4	-6
Operating Cash Flow	-3	-3	-2	-3	-5	-4	-1	-1	-5
Investing Cash Flow	-	0	0	0	0	0	0	0	0
Financing Cash Flow	4	10	0	15	15	-	-	-	1
Change in Cash	1	6	-2	11	-5	-4	-2	-1	-4

Immix Biopharma Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-24	-8	-15	-21
Operating Cash Flow	0	-1	-7	-11	-14
Investing Cash Flow	0	0	-	0	-1
Financing Cash Flow	18	18	3	15	15
Change in Cash	0	17	-4	4	0

Global Institutional Holdings in Immix Biopharma Inc

Funds	Holdings
Bleichroeder LP	2.95%
Vanguard Group Inc	2.42%
Geode Capital Management, LLC	0.56%
Morgan Stanley - Brokerage Accounts	0.43%
Northern Trust Corp	0.33%

See all

Insights on Immix Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, IMMX stock has moved up by 75.6%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 188.7% return, outperforming this stock by 59.3%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 1021.4% return, outperforming this stock by 754.4%

About Immix Biopharma Inc

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and select immune-mediated diseases. The Company's lead cell therapy candidate CAR-T NXC-201 (NXC-201), which is being evaluated in its ongoing United States Phase Ib/II NEXICART-2 (NCT06097832) clinical trial. Its lead program, NXC-201 is a next generation CAR-T targeting B-cell maturation antigen. CAR-T cell therapy is a type of immunotherapy that uses the patient’s own immune cells, modified with its proprietary technology. Its N-GENIUS cell engineering platform with EXPAND technology has produced clinical-stage CAR-T NXC-201, targeting B cell maturation antigen, which is autologous CAR-T being developed to treat AL Amyloidosis.

Organisation	Immix Biopharma Inc
Headquarters	11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064
CEO	Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
E-voting on shares	Click here to vote

Key Management of Immix Biopharma Inc

Name	Title
Mr. Sean Senn J.D., M.B.A., M.Sc., MBA, MSc	Co-Founder
Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.	Scientific Co-Founder
Dr. David Marks MBBS, Ph.D.	Chief Medical Officer of Cell Therapy
Mr. Mel Davis-Pickett	Head of CMC Technical Development
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.	Co-Founder, CEO & Chairman
Mr. Gabriel Morris B.A.	CFO & Director
Dr. Graham Ross FFPM, M.D.	Chief Medical Officer & Head of Clinical Development

FAQs

What is Immix Biopharma Inc share price today?

Immix Biopharma Inc share price today is $3.67 as on October 31, 2025 at 1:29 am IST at the close of the market. Immix Biopharma Inc share today touched a day high of $3.85 and a low of $3.6.

What is the 52 week high and 52 week low for Immix Biopharma Inc share?

Immix Biopharma Inc share touched a 52 week high of $4 on October 28, 2025 and a 52 week low of $1.34 on April 8, 2025. Immix Biopharma Inc stock price today i.e. October 31, 2025 at 1:29 am IST is closed at $3.67,which is 8.25% down from its 52 week high and 173.88% up from its 52 week low.

What is Immix Biopharma Inc's market capitalisation today?

Immix Biopharma Inc market capitalisation is $0.00T as on October 31, 2025 at 1:29 am IST.

How to invest in Immix Biopharma Inc Stock (IMMX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Immix Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immix Biopharma Inc Shares that will get you 0.4087 shares as per Immix Biopharma Inc share price of $3.67 per share as on October 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immix Biopharma Inc Stock (IMMX) from India?

Indian investors can start investing in Immix Biopharma Inc (IMMX) shares with as little as ₹88.686 or $1 (as of October 31, 2025 at 12:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Immix Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on October 31, 2025 at 12:38 pm IST). Based on Immix Biopharma Inc share’s latest price of $3.67 as on October 31, 2025 at 1:29 am IST, you will get 2.7248 shares of Immix Biopharma Inc. Learn more about fractional shares .